共 354 条
- [71] Kerman R.(1995)Important interactions of drugs with immunosuppressive agents used in transplant recipients J An- timicrobial Chemother 36Suppl.B 11-43
- [72] Flechner S.M.(1993)5’-Nucleotidase and azathioprine-related toxicity Lancet 342 1245-53
- [73] van Buren C.T.(1989)Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and ther- apeutic use in immunoregulatory disorders Cyclosporin. N Engl J Med 321 1725-53
- [74] Jarowenko M.(1993)The absorption site of cyclosporin in the human gastrointestinal tract Drugs 45 953-24
- [75] Flechner S.M.(1992)Pharmacokinetics of cyclosporin in human renal transplantation Br J Clin Pharmacol 33 39-90
- [76] Lorber M.(1983)Effect of food on the pharmacokinetics of cyclosporin in healthy subjects following oral and intravenous administration Transplant Proc 15 446-32
- [77] van Buren C.T.(1990)The effect of grapefruit juice on cyclosporin and prednisone metabolism in transplant patients J Clin Pharmacol 30 643-15
- [78] Canafax D.M.(1995)Cyclosporin metabolism in human liver: identification of a cytochrome P450 III gene family as the major cyclosporin metabolizing enzyme explains interactions of cyclosporin with other drugs Clin Pharmacol Ther 57 318-7
- [79] Sutherland D.E.R.(1988)First pass metabolism of cyclosporin by the gut Clin Pharmacol Ther 43 6305-20
- [80] Ascher N.L.(1991)Pharmacokinetic drug interactions with cyclosporin (Part I) Lancet 338 1488-3